4//SEC Filing
Neos Therapeutics, Inc. 4
Accession 0001104659-15-053967
CIK 0001467652operating
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 8:27 PM ET
Size
6.9 KB
Accession
0001104659-15-053967
Insider Transaction Report
Form 4
Engelking Dorothy
VP, Regulatory Affairs
Transactions
- Conversion
Series C Preferred Stock
2015-07-28−1,000→ 0 total→ Common Stock (416 underlying) - Conversion
Common Stock
2015-07-28+416→ 416 total
Footnotes (1)
- [F1]Each share of the Issuer's Series C preferred stock was automatically converted on a 2.4-for-1 basis into common stock immediately prior to the closing of the Issuer's initial public offering. The shares of Series C preferred stock had no expiration date.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001467652
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 8:27 PM ET
- Size
- 6.9 KB